Subscribe
Sign In
Tag: CBT > DEA Rescheduling
California
California Wildfires, Cannabis Rescheduling, Wisconsin Legalization Lead CBT’s Top Stories in January
The natural disaster in California led to supply chain disruptions and confusion, with details about its impact at the forefront of the most-read articles this month.
January 30, 2025
Cannabis Rescheduling
Cannabis Rescheduling Participant Never Consented to Interlocutory Appeal Motion
Cannabis attorney says an ‘inadvertent error’ led to Ellen Brown’s inclusion on the motion for an appeal that she ‘vehemently’ opposes.
January 27, 2025
Cannabis Rescheduling
DEA Judge Sends Interlocutory Appeal to Administrator; Recommends All Participants Be Included
The judge asked DEA Administrator Anne Milgram to include all designated participants for the cannabis rescheduling hearing to be part of a briefing schedule.
January 16, 2025
Cannabis Rescheduling
Village Farms International Comments on Delayed Cannabis Rescheduling Process
The hearing’s designated participant views the delay as an imperative administrative step and symbolic win for the industry against a ‘conflicted’ DEA.
January 15, 2025
Cannabis Rescheduling
DEA Judge Grants Interlocutory Appeal, Cancels Cannabis Rescheduling Hearing
The rescheduling proceedings won’t pick up for at least 90 days—if at all—pending a resolution of the appeal to the DEA administrator.
January 14, 2025
Cannabis Rescheduling
DEA Responds to ‘Out of Time’ Cannabis Rescheduling Claims
In response to cannabis advocates’ renewed motion to disqualify the DEA from the hearing process, the DEA says there is no new evidence to reconsider.
January 13, 2025
Cannabis Rescheduling
Interlocutory Appeal Could Derail Cannabis Rescheduling Hearing
New evidence prompted rescheduling advocates’ second effort to oust the DEA from the hearing; if relief is denied, they will seek the appeal.
January 8, 2025
Industry Headlines
DEA Approves Marion McNabb as Expert Witness for Cannabis Rescheduling Hearing
The doctor in public health will testify as a proponent for reclassifying cannabis to a Schedule III drug under the Controlled Substances Act.
January 7, 2025
Top Stories
Top 10 Articles of 2024: Farm Bill, Ohio Legalization, Rescheduling Lead CBT’s Coverage
Here’s a roundup of Cannabis Business Times’ most-viewed stories that readers did not want to miss out on from the past year.
December 31, 2024
Top Stories
Bat Poop Fatalities, Farm Bill Extension Lead CBT’s Top Stories in December
Illinois legislation to regulate hemp products, the DEA’s subpoena blunder and Minnesota’s unknown launch were among the most-read articles this month.
December 26, 2024
Top Stories
Judge Calls DEA Subpoena Request ‘Blunder,’ Rejects 3 of 4 for Cannabis Rescheduling Hearing
Administrative Law Judge John Mulrooney points out the DEA’s error yet provides the agency another shot at subpoenaing three FDA officials.
December 17, 2024
Industry Headlines
Cannabis Bioscience Fights to Include Longtime Patient as Witness in DEA Rescheduling Hearing
As a designated participant, the company filed a petition to allow testimony from Alexis Bortell, who was diagnosed with intractable epilepsy as a child.
December 16, 2024
Page 1 of 11
Next Page